Skip to main content

Table 2 Probability of a dose exceeding a target response (adjusted for placebo) (mITT population)

From: Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

UMEC dose

Probability (%) of exceeding a specified change from baseline FEV1at trough (Day 8 dataset)

0.075 L

0.100 L

0.120 L

0.150 L

15.6 μg QD

43

21

11

3

31.25 μg QD

88

74

56

30

62.5 μg QD

95

87

77

52

125 μg QD

99

100

99

92

15.6 μg BID

89

75

59

33

31.25 μg BID

78

60

44

21

  1. BID, twice daily; FEV1, forced expiratory volume in 1 second; QD, once daily; UMEC, umeclidinium bromide.